Current trends in erectile rehabilitation after radical prostatectomy: Results from a worldwide survey.

erectile rehabilitation intracavernous injection therapy phosphodiesterase's 5 inhibitors radical prostatectomy surveys and questionnaires

Journal

Andrologia
ISSN: 1439-0272
Titre abrégé: Andrologia
Pays: Germany
ID NLM: 0423506

Informations de publication

Date de publication:
Oct 2022
Historique:
revised: 16 05 2022
received: 23 03 2022
accepted: 09 06 2022
pubmed: 6 7 2022
medline: 8 9 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

We aimed to analyse the current trend of erectile rehabilitation (ER) following radical prostatectomy (RP) using a dedicated survey. An online survey was developed between July and September 2020, aiming to evaluate the ER protocols after RP in daily practice among urologists, andrologists, sexual medicine specialists and residents. We investigated demographics data, type of RP performed, and type, schedule, timing and duration of ER protocols. In total, 518 responders from 52 countries completed the survey. Surgical techniques reported were: 38.9% open, 22.9% laparoscopic and 38.2% robot-assisted RP. 33% of the responders begin ER at the catheter removal, 22% 1 month after surgery and 15% before surgery. Phosphodiesterase inhibitors were the most used medication as first-line treatment (99.4%). Tadalafil 20 mg was the most prescribed, and used daily in 48.2% of the cases, and 2-3 times/week in 46%. Intra-cavernosal injection of prostaglandin E1 was the second most common prescribed monotherapy (67.9%) followed by the association of phosphodiesterase inhibitors and vacuum-erection device (29.6%). The duration of ER was <6 months in 16.2%, between 6 and 11 months in 39%, between 12 and 18 months in 31.9%, between 19-24 months in 9.2% and >24 months in 3.7%. This study showed that the approach to ER after RP was inhomogeneous. International guidelines are urgently needed to standardise ER protocols.

Identifiants

pubmed: 35780809
doi: 10.1111/and.14506
doi:

Substances chimiques

Phosphodiesterase Inhibitors 0
Tadalafil 742SXX0ICT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14506

Informations de copyright

© 2022 Wiley-VCH GmbH.

Références

Basal, S., Wambi, C., Acikel, C., Gupta, M., & Badani, K. (2013). Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function. BJU International, 111(4), 658-665. https://doi.org/10.1111/j.1464-410X.2012.11487.x
Capogrosso, P., Vertosick, E. A., Benfante, N. E., Eastham, J. A., Scardino, P. J., Vickers, A. J., & Mulhall, J. P. (2019). Are we improving erectile function recovery after radical prostatectomy? Analysis of patients treated over the last decade. European Urology, 75(2), 221-228. https://doi.org/10.1016/j.eururo.2018.08.039
Della Camera, P. A., Tellini, R., Cito, G., Rastrelli, G., Maggi, M., Chini, T., De Nunzio, C., Altieri, V. M., Serni, S., Gacci, M., & Natali, A. (2020). Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study. Urologia, 87(1), 23-28. https://doi.org/10.1177/0391560319867809
Giuliano, F., Amar, E., Chevallier, D., Montaigne, O., Joubert, J.-M., & Chartier-Kastler, E. (2008). How urologists manage erectile dysfunction after radical prostatectomy: A national survey (REPAIR) by the French Urological Association. The Journal of Sexual Medicine, 5(2), 448-457. https://doi.org/10.1111/j.1743-6109.2007.00670.x
Gudaru, K., Gonzalez Padilla, D. A., Castellani, D., Blanco, L. T., Tanidir, Y., Lun, L. K., Wroclawski, M. L., Maheshwari, P. N., De Figueiredo, F. C. A., & Teoh, J. Y.-C. (2020). A global knowledge, attitudes and practices survey on anatomical endoscopic enucleation of prostate for benign prostatic hyperplasia among urologists. Andrologia, 52(8), e137. https://doi.org/10.1111/and.13717
Hatzimouratidis, K., Burnett, A. L., Hatzichristou, D., McCullough, A. R., Montorsi, F., & Mulhall, J. P. (2009). Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: A critical analysis of the basic science rationale and clinical application. European Urology, 55(2), 334-347. https://doi.org/10.1016/j.eururo.2008.10.028
Jo, J. K., Jeong, S. J., Oh, J. J., Lee, S. W., Lee, S., Hong, S. K., Byun, S. S., & Lee, S. E. (2018). Effect of starting penile rehabilitation with sildenafil immediately after robot-assisted laparoscopic radical prostatectomy on erectile function recovery: A prospective randomized trial. The Journal of Urology, 199(6), 1600-1606. https://doi.org/10.1016/j.juro.2017.12.060
Kacker, R., Morgentaler, A., & Traish, A. (2014). Medical hypothesis: Loss of the endocrine function of the prostate is important to the pathophysiology of postprostatectomy erectile dysfunction. The Journal of Sexual Medicine, 11(8), 1898-1902. https://doi.org/10.1111/jsm.12574
Kim, S., & Sung, G. T. (2018). Efficacy and safety of tadalafil 5 mg once daily for the treatment of erectile dysfunction after robot-assisted laparoscopic radical prostatectomy: A 2-year follow-up. Sexual Medicine, 6(2), 108-114. https://doi.org/10.1016/j.esxm.2017.12.005
Marchioni, M., de Francesco, P., Castellucci, R., Papalia, R., Sarikaya, S., Gomez Rivas, J., Schips, L., Scarpa, R. M., & Esperto, F. (2020). Management of erectile dysfunction following robot-assisted radical prostatectomy: A systematic review. Minerva Urologica e Nefrologica, 72(5), 543-554. https://doi.org/10.23736/S0393-2249.20.03780-7
Montorsi, F., Guazzoni, G., Strambi, L. F., da Pozzo, L. F., Nava, L., Barbieri, L., Rigatti, P., Pizzini, G., & Miani, A. (1997). Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial. The Journal of Urology, 158(4), 1408-1410.
Montorsi, F., Brock, G., Stolzenburg, J.-U., Mulhall, J., Moncada, I., Patel, H. R. H., Chevallier, D., Krajka, K., Henneges, C., Dickson, R., & Büttner, H. (2014). Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: A randomised placebo-controlled study (REACTT). European Urology, 65(3), 587-596. https://doi.org/10.1016/j.eururo.2013.09.051
Montorsi, F., Nathan, H. P., McCullough, A., Brock, G. B., Broderick, G., Ahuja, S., Whitaker, S., Hoover, A., Novack, D., Murphy, A., & Varanese, L. (2004). Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: A randomized, double-blind, placebo controlled trial. The Journal of Urology, 172(3), 1036-1041. https://doi.org/10.1097/01.ju.0000136448.71773.2b
Oberlin, D. T., Flum, A. S., Lai, J. D., & Meeks, J. J. (2016). The effect of minimally invasive prostatectomy on practice patterns of American urologists. Urologic Oncology, 34(6), 255.e1-255.e5. https://doi.org/10.1016/j.urolonc.2016.01.008
Resnick, M. J., Koyama, T., Fan, K.-H., Albertsen, P. C., Goodman, M., Hamilton, A. S., Hoffman, R. M., Potosky, A. L., Stanford, J. L., Stroup, A. M., van Horn, R., & Penson, D. F. (2013). Long-term functional outcomes after treatment for localized prostate cancer. The New England Journal of Medicine, 368(5), 436-445. https://doi.org/10.1056/NEJMoa1209978
Salonia, A., Adaikan, G., Buvat, J., Carrier, S., el-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Khera, M. (2017a). Sexual rehabilitation after treatment for prostate cancer-Part 2: Recommendations from the fourth international consultation for sexual medicine (ICSM 2015). The Journal of Sexual Medicine, 14(3), 297-315. https://doi.org/10.1016/j.jsxm.2016.11.324
Salonia, A., Adaikan, G., Buvat, J., Carrier, S., el-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Khera, M. (2017b). Sexual rehabilitation after treatment for prostate cancer-Part 1: Recommendations from the fourth international consultation for sexual medicine (ICSM 2015). The Journal of Sexual Medicine, 14, 285-296. https://doi.org/10.1016/j.jsxm.2016.11.325
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., Mahadevan, A., Klein, E., Kibel, A., Pisters, L. L., Kuban, D., Kaplan, I., Wood, D., Ciezki, J., Shah, N., & Wei, J. T. (2008). Quality of life and satisfaction with outcome among prostate-cancer survivors. The New England Journal of Medicine, 358(12), 1250-1261. https://doi.org/10.1056/NEJMoa074311
Secin, F. P., Touijer, K., Mulhall, J., & Guillonneau, B. (2007). Anatomy and preservation of accessory pudendal arteries in laparoscopic radical prostatectomy. European Urology, 51(5), 1229-1235. https://doi.org/10.1016/j.eururo.2006.08.030
Tal, R., Teloken, P., & Mulhall, J. P. (2011). Erectile function rehabilitation after radical prostatectomy: Practice patterns among AUA members. The Journal of Sexual Medicine, 8(8), 2370-2376. https://doi.org/10.1111/j.1743-6109.2011.02355.x
Teloken, P. E., Mesquita, G., Montorsi, F., & Mulhall, J. (2009). Post-radical prostatectomy pharmacological penile rehabilitation: Practice patterns among the international society for sexual medicine practitioners. The Journal of Sexual Medicine, 6(7), 2032-2038. https://doi.org/10.1111/j.1743-6109.2009.01269.x
Teoh, J. Y. C., Ong, W. L. K., Gonzalez-Padilla, D., Castellani, D., Dubin, J. M., Esperto, F., Campi, R., Gudaru, K., Talwar, R., Okhunov, Z., Ng, C. F., Jain, N., Gauhar, V., Wong, M. C., Wroclawski, M. L., Tanidir, Y., Rivas, J. G., Tiong, H. Y., Loeb, S., & UroSoMe Working Group. (2020). A global survey on the impact of COVID-19 on urological services. European Urology, 78(2), 265-275. https://doi.org/10.1016/j.eururo.2020.05.025
Walz, J., Epstein, J. I., Ganzer, R., Graefen, M., Guazzoni, G., Kaouk, J., Menon, M., Mottrie, A., Myers, R. P., Patel, V., Tewari, A., Villers, A., & Artibani, W. (2016). A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimisation of cancer control and preservation of continence and erection in candidates for radical prostatectomy: An update. European Urology, 70(2), 301-311. https://doi.org/10.1016/j.eururo.2016.01.026
Wang, R. (2017). Vacuum erectile device for rehabilitation after radical prostatectomy. The Journal of Sexual Medicine, 14(2), 184-186. https://doi.org/10.1016/j.jsxm.2016.12.010
Weight, C. J., Crispen, P. L., Breau, R. H., Kim, S. P., Lohse, C. M., Boorjian, S. A., Thompson, R. H., & Leibovich, B. C. (2013). Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American urologic association surgeons. BJU International, 111(5), 731-738. https://doi.org/10.1111/j.1464-410X.2012.11112.x

Auteurs

Emanuele Rubilotta (E)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy.

Marilena Gubbiotti (M)

Department of Urology, San Donato Hospital, Arezzo, Italy.

Matteo Balzarro (M)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy.

Daniele Castellani (D)

Faculty of Medicine, School of Urology, Le Marche Polytechnic University, Ancona, Italy.

Giacomo Maria Pirola (GM)

Department of Urology, San Donato Hospital, Arezzo, Italy.

Luca Gemma (L)

Department of Urology, Careggi Hospital, Florence, Italy.

Jeremy Yuen-Chen Teoh (JY)

S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.

Anastasia Polykarpova (A)

SM-Clinic, RUDN University, Moscow, Russia.

Ana Maria Autrán-Gómez (AM)

Research Office of Confederación Americana de Urología (CAU), Madrid, Spain.

Leonardo Tortolero Blanco (L)

Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.

Filippo Migliorini (F)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy.

Alessandro Tafuri (A)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy.
Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University, Chieti-Pescara, Italy.

Alessandro Antonelli (A)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH